☆ 4.7 Letter

Effect of Lowering Home Blood Pressure on Subclinical Cardiovascular Disease in Masked Uncontrolled Hypertension

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Get Full Text
Add to Collection

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 71, Issue 24, Pages 2858-2859

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.04.017

Keywords

-

Categories

Cardiac & Cardiovascular Systems

Funding

  1. National Institute of General Medical Sciences of the National Institutes of Health [P20GM104357]
  2. Teijin Pharma Limited
  3. Omron Healthcare Co., Ltd.
  4. Fukuda Denshi
  5. Bayer Yakuhin Ltd.
  6. AD Co., Ltd.
  7. Daiichi-Sankyo Company Limited
  8. Mochida Pharmaceutical Co., Ltd.
  9. EA Pharma
  10. Boehringer Ingelheim Japan Inc.
  11. Tanabe Mitsubishi Pharma Corporation
  12. Shionogi Co., Ltd.
  13. MSD K.K.
  14. Sanwa Kagaku Kenkyusho Co., Ltd.
  15. Bristol-Myers Squibb K.K.

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.